KYUNGHEE SEO: Open Payments
NPI 1073903100 · LAKEWOOD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 27 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $115 · 2025 $756
Food & beverage: $756
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $229 |
| ABBVIE INC. | 3 | $146 |
| PFIZER INC. | 3 | $74 |
| Kowa Pharmaceuticals America, Inc. | 4 | $73 |
| Esperion Therapeutics, Inc. | 2 | $42 |
| Novo Nordisk Inc | 2 | $34 |
| Azurity Pharmaceuticals, Inc. | 1 | $34 |
| Amgen Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: AIRSUPRA, BOTOX, ZORYVE, NEXLETOL, HORIZANT, OTEZLA, PAXLOVID, SHINGRIX.
Industry payments across WA — which companies pay providers there.
